Friday, October 22, 2010

Sold Momenta Pharmaceuticals

I don’t like the tape action here and it looks a bit tired so I’m raising some cash. I took some quick profits in Momenta Pharmaceuticals (Ticker: MNTA) at $15.49 generating a 3.26% gain over a two day period. Everyone is hoping that Momenta Pharmaceutical remains the only Lovenex generic player, but that is doubtful. Teva Pharmaceuticals (Ticker: TEVA) is expected to receive approval at any moment. This will lower the profit sharing agreement between Momenta Pharmaceuticals and Sandoz. Right now, Momenta Pharmaceuticals is in a sweet spot, but I don’t think it will last much longer.


At October 22, 2010, Anonymous Anonymous said...

You failed to do your homework.

TEVA said they were getting approval several months ago. What happened??

TEVA's generic LOVENOX is being manufactured & distributed by a 3rd party. The FDA will not approve their generic since the FDA has established a 5 point criteria. TEVA doesn't have the technical skill that MNTA has (via patents).

MNTA 3Q earnings will be out Nov. 1. Most analysts predict .68+

At October 22, 2010, Blogger Money Turtle said...

Thanks for the feed back. I know I'm lazy sometimes and don't do my homework completely. I may get back in Momenta...


Post a Comment

<< Home